Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gastrointestinal 2Dermatologic 1

Conditions

Breast Neoplasms 3Pain, Postoperative 1Pain 1Chronic Pain 1Agnosia 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Nerve Block × Breast × Clear all
NCT01089933 2025-04-04

RELIeF

Ottawa Hospital Research Institute

Phase NA Completed
129 enrolled 6 charts
Breast

Agnosia, Breast Neoplasms, Chronic Pain

NCT06608810 2024-09-23

PECS II

Inner Mongolia Baogang Hospital

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

NCT04086394 2020-02-20

PECS

Main Line Health

Phase NA Unknown
130 enrolled
Breast

Breast Neoplasms, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡